Sphingosylphosphorylcholine inhibits macrophage adhesion to vascular smooth muscle cells

Christiane Wirrig, Jenny S. McKean, Heather M. Wilson, Graeme F. Nixon

Research output: Contribution to journalArticle

1 Citation (Scopus)
8 Downloads (Pure)

Abstract

Inflammation in de-endothelialized arteries contributes to the development of cardiovascular diseases. The process that initiates this inflammatory response is the adhesion of monocytes/macrophages to exposed vascular smooth muscle cells, typically stimulated by cytokines such as tumour necrosis factor- (TNF). The aim of this study was to determine the effect of the sphingolipid sphingosylphosphorylcholine (SPC) on the interaction of monocytes/macrophages with vascular smooth muscle cells. Rat aortic smooth muscle cells and rat bone marrow-derived macrophages were co-cultured using an in vitro assay following incubation with sphingolipids to assess inter-cellular adhesion. We reveal that SPC inhibits the TNF-induced adhesion of macrophages to smooth muscle cells. This anti-adhesive effect was the result of SPC-induced changes to the smooth muscle cells (but not the macrophages) and was mediated, at least partly, via the sphingosine 1-phosphate receptor subtype 2. Lipid raft domains were also required. Although SPC did not alter expression or membrane distribution of the adhesion proteins intercellular adhesion molecule-1 and vascular cellular adhesion protein-1 in smooth muscle cells, SPC preincubation inhibited the TNF-induced increase in inducible nitric oxide synthase (NOS2) resulting in a subsequent decrease in nitric oxide production. Inhibiting NOS2 activation in smooth muscle cells led to a decrease in the adhesion of macrophages to smooth muscle cells. This study has therefore delineated a novel pathway which can inhibit the interaction between macrophages and vascular smooth muscle cells via SPC-induced repression of NOS2 expression. This mechanism could represent a potential drug target in vascular disease.
Original languageEnglish
Pages (from-to)43-50
Number of pages8
JournalBiochemical Pharmacology
Volume115
Early online date8 Jul 2016
DOIs
Publication statusPublished - 1 Sep 2016

Fingerprint

Macrophages
Vascular Smooth Muscle
Smooth Muscle Myocytes
Muscle
Adhesion
Cells
Sphingolipids
Tumor Necrosis Factor-alpha
Rats
Monocytes
Lysosphingolipid Receptors
sphingosine phosphorylcholine
Nitric Oxide Synthase Type II
Intercellular Adhesion Molecule-1
Vascular Diseases
Adhesives
Blood Vessels
Assays
Nitric Oxide
Bone

Keywords

  • Vascular smooth muscle
  • Sphingolipids
  • Macrophage
  • Nitric oxide synthase
  • Lipid raft

Cite this

Sphingosylphosphorylcholine inhibits macrophage adhesion to vascular smooth muscle cells. / Wirrig, Christiane; McKean, Jenny S.; Wilson, Heather M.; Nixon, Graeme F.

In: Biochemical Pharmacology, Vol. 115, 01.09.2016, p. 43-50.

Research output: Contribution to journalArticle

@article{68694ad3dee748cdb585157b3f0a9bfe,
title = "Sphingosylphosphorylcholine inhibits macrophage adhesion to vascular smooth muscle cells",
abstract = "Inflammation in de-endothelialized arteries contributes to the development of cardiovascular diseases. The process that initiates this inflammatory response is the adhesion of monocytes/macrophages to exposed vascular smooth muscle cells, typically stimulated by cytokines such as tumour necrosis factor- (TNF). The aim of this study was to determine the effect of the sphingolipid sphingosylphosphorylcholine (SPC) on the interaction of monocytes/macrophages with vascular smooth muscle cells. Rat aortic smooth muscle cells and rat bone marrow-derived macrophages were co-cultured using an in vitro assay following incubation with sphingolipids to assess inter-cellular adhesion. We reveal that SPC inhibits the TNF-induced adhesion of macrophages to smooth muscle cells. This anti-adhesive effect was the result of SPC-induced changes to the smooth muscle cells (but not the macrophages) and was mediated, at least partly, via the sphingosine 1-phosphate receptor subtype 2. Lipid raft domains were also required. Although SPC did not alter expression or membrane distribution of the adhesion proteins intercellular adhesion molecule-1 and vascular cellular adhesion protein-1 in smooth muscle cells, SPC preincubation inhibited the TNF-induced increase in inducible nitric oxide synthase (NOS2) resulting in a subsequent decrease in nitric oxide production. Inhibiting NOS2 activation in smooth muscle cells led to a decrease in the adhesion of macrophages to smooth muscle cells. This study has therefore delineated a novel pathway which can inhibit the interaction between macrophages and vascular smooth muscle cells via SPC-induced repression of NOS2 expression. This mechanism could represent a potential drug target in vascular disease.",
keywords = "Vascular smooth muscle, Sphingolipids, Macrophage, Nitric oxide synthase, Lipid raft",
author = "Christiane Wirrig and McKean, {Jenny S.} and Wilson, {Heather M.} and Nixon, {Graeme F.}",
note = "Acknowledgement CW and JSMcK were funded by British Heart Foundation studentships.",
year = "2016",
month = "9",
day = "1",
doi = "10.1016/j.bcp.2016.07.004",
language = "English",
volume = "115",
pages = "43--50",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Sphingosylphosphorylcholine inhibits macrophage adhesion to vascular smooth muscle cells

AU - Wirrig, Christiane

AU - McKean, Jenny S.

AU - Wilson, Heather M.

AU - Nixon, Graeme F.

N1 - Acknowledgement CW and JSMcK were funded by British Heart Foundation studentships.

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Inflammation in de-endothelialized arteries contributes to the development of cardiovascular diseases. The process that initiates this inflammatory response is the adhesion of monocytes/macrophages to exposed vascular smooth muscle cells, typically stimulated by cytokines such as tumour necrosis factor- (TNF). The aim of this study was to determine the effect of the sphingolipid sphingosylphosphorylcholine (SPC) on the interaction of monocytes/macrophages with vascular smooth muscle cells. Rat aortic smooth muscle cells and rat bone marrow-derived macrophages were co-cultured using an in vitro assay following incubation with sphingolipids to assess inter-cellular adhesion. We reveal that SPC inhibits the TNF-induced adhesion of macrophages to smooth muscle cells. This anti-adhesive effect was the result of SPC-induced changes to the smooth muscle cells (but not the macrophages) and was mediated, at least partly, via the sphingosine 1-phosphate receptor subtype 2. Lipid raft domains were also required. Although SPC did not alter expression or membrane distribution of the adhesion proteins intercellular adhesion molecule-1 and vascular cellular adhesion protein-1 in smooth muscle cells, SPC preincubation inhibited the TNF-induced increase in inducible nitric oxide synthase (NOS2) resulting in a subsequent decrease in nitric oxide production. Inhibiting NOS2 activation in smooth muscle cells led to a decrease in the adhesion of macrophages to smooth muscle cells. This study has therefore delineated a novel pathway which can inhibit the interaction between macrophages and vascular smooth muscle cells via SPC-induced repression of NOS2 expression. This mechanism could represent a potential drug target in vascular disease.

AB - Inflammation in de-endothelialized arteries contributes to the development of cardiovascular diseases. The process that initiates this inflammatory response is the adhesion of monocytes/macrophages to exposed vascular smooth muscle cells, typically stimulated by cytokines such as tumour necrosis factor- (TNF). The aim of this study was to determine the effect of the sphingolipid sphingosylphosphorylcholine (SPC) on the interaction of monocytes/macrophages with vascular smooth muscle cells. Rat aortic smooth muscle cells and rat bone marrow-derived macrophages were co-cultured using an in vitro assay following incubation with sphingolipids to assess inter-cellular adhesion. We reveal that SPC inhibits the TNF-induced adhesion of macrophages to smooth muscle cells. This anti-adhesive effect was the result of SPC-induced changes to the smooth muscle cells (but not the macrophages) and was mediated, at least partly, via the sphingosine 1-phosphate receptor subtype 2. Lipid raft domains were also required. Although SPC did not alter expression or membrane distribution of the adhesion proteins intercellular adhesion molecule-1 and vascular cellular adhesion protein-1 in smooth muscle cells, SPC preincubation inhibited the TNF-induced increase in inducible nitric oxide synthase (NOS2) resulting in a subsequent decrease in nitric oxide production. Inhibiting NOS2 activation in smooth muscle cells led to a decrease in the adhesion of macrophages to smooth muscle cells. This study has therefore delineated a novel pathway which can inhibit the interaction between macrophages and vascular smooth muscle cells via SPC-induced repression of NOS2 expression. This mechanism could represent a potential drug target in vascular disease.

KW - Vascular smooth muscle

KW - Sphingolipids

KW - Macrophage

KW - Nitric oxide synthase

KW - Lipid raft

U2 - 10.1016/j.bcp.2016.07.004

DO - 10.1016/j.bcp.2016.07.004

M3 - Article

VL - 115

SP - 43

EP - 50

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

ER -